BlackRock Fund Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

BlackRock Fund Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$90K	Buy	38,641 +8,640	+29%	+$16.5K	﹤0.01%	3636
2016 Q3	$50K	Buy	30,001 +3,159	+12%	+$3.87K	﹤0.01%	3779
2016 Q2	$28K	Sell	26,842 -3,994,330	-99%	-$3.86M	﹤0.01%	3876
2016 Q1	$3.5M	Sell	4,021,172 -86,313	-2%	-$83.5K	﹤0.01%	2912
2015 Q4	$4.97M	Buy	4,107,485 +78,174	+2%	+$109K	﹤0.01%	2837
2015 Q3	$6.85M	Buy	4,029,311 +68,979	+2%	+$135K	﹤0.01%	2598
2015 Q2	$8.24M	Buy	3,960,332 +652,361	+20%	+$1.58M	﹤0.01%	2619
2015 Q1	$8.96M	Buy	3,307,971 +64,194	+2%	+$163K	﹤0.01%	2500
2014 Q4	$8.34M	Buy	3,243,777 +429,797	+15%	+$965K	﹤0.01%	2566
2014 Q3	$5.15M	Sell	2,813,980 -85,306	-3%	-$186K	﹤0.01%	2739
2014 Q2	$7.74M	Sell	2,899,286 -273,537	-9%	-$823K	﹤0.01%	2576
2014 Q1	$11.1M	Buy	3,172,823 +94,523	+3%	+$419K	﹤0.01%	2340
2013 Q4	$13.8M	Sell	3,078,300 -114,635	-4%	-$467K	﹤0.01%	2195
2013 Q3	$13M	Buy	3,192,935 +382,914	+14%	+$1.67M	﹤0.01%	2205
2013 Q2	$11.7M	Buy	+2,810,021	New	+$10.9M	﹤0.01%	2172

Other funds holding ATRS

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock Fund Advisors's ATRS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Antares Pharma, Inc. (ATRS) stake by 29% in Q4 2016, buying an estimated $16.5K and bringing the position to 38,641 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

BlackRock Fund Advisors first reported a position in ATRS in Q2 2013 and has held it in 15 quarters since. The position peaked at $13.8M in Q4 2013. 71 funds tracked by Wall St. Rank hold ATRS as of Q4 2016.

BlackRock Fund Advisors held 38,641 shares of Antares Pharma, Inc. worth $90K as of Q4 2016.
BlackRock Fund Advisors bought 8,640 Antares Pharma, Inc. shares in Q4 2016, an estimated $16.5K.
Antares Pharma, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3636 holding.
BlackRock Fund Advisors first reported a position in Antares Pharma, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Antares Pharma, Inc. position peaked at $13.8M in Q4 2013.
71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.